Genome‐wide association studies of exacerbations in children using long‐acting beta2‐agonists

BACKGROUND: Some children with asthma experience exacerbations despite long‐acting beta2‐agonist (LABA) treatment. While this variability is partly caused by genetic variation, no genome‐wide study until now has investigated which genetic factors associated with risk of exacerbations despite LABA us...

Descripción completa

Detalles Bibliográficos
Autores principales: Slob, Elise M. A., Richards, Levi B., Vijverberg, Susanne J. H., Longo, Cristina, Koppelman, Gerard H., Pijnenburg, Mariëlle W. H., Bel, Elisabeth H. D., Neerincx, Anne H., Herrera Luis, Esther, Perez‐Garcia, Javier, Tim Chew, Fook, Yie Sio, Yang, Andiappan, Anand K., Turner, Steve W., Mukhopadhyay, Somnath, Palmer, Colin N. A., Hawcutt, Daniel, Jorgensen, Andrea L., Burchard, Esteban G., Hernandez‐Pacheco, Natalia, Pino‐Yanes, Maria, Maitland‐van der Zee, Anke H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
ORIGINAL ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8328929/
https://www.ncbi.nlm.nih.gov/pubmed/33706416
http://dx.doi.org/10.1111/pai.13494

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8328929/
https://www.ncbi.nlm.nih.gov/pubmed/33706416
http://dx.doi.org/10.1111/pai.13494

Ejemplares similares